Saturday, 19 January, 2019

Company recalls portion of narcotic overdose reversal drug

Company recalls portion of narcotic overdose reversal drug Company recalls portion of narcotic overdose reversal drug
Melissa Porter | 07 June, 2018, 19:40

Initially, the Naloxone drug was available only at the hospitals but now; it is being carried by several medical professionals and first responders and is available in certain places without even a prescription, all of this in response to the current opioid addiction and epidemic which looks to get worse with time.

So far, there are no reports of issues or injuries from recalled syringes.

The FDA and drug maker Pfizer have issued a recall on two lots of Naloxone, the opioid overdose reversal drug, due to potential particulate matter in the syringes.

According to CNN, the deliveries in question were sent to wholesalers, distributors, and hospitals in the United States, including Puerto Rico and Guam. There's a quick-acting antidote to save them called naloxone or Narcan.

Hancock Public Health, which provides naloxone kits to the community, says its kits are not affected by a nationwide recall. Patients who come into contact with the particulate matter may suffer from the following local irritation, allergic reactions, phlebitis, end-organ granuloma, tissue ischemia, pulmonary emboli, pulmonary dysfunction, pulmonary infarction, and toxicity.

Naloxone is sold for IV, intramuscular, and subcutaneous use.

The recall includes single use sterile cartridge units with lot numbers 72680LL and 76510LL in 0.4 mg/ml, 1 mL in, and 2.5 mL strengths.

People can survive an overdose, but it comes down to timing. It has asked distributors and retailers to stop using the recalled Naloxone.

Some of the states that were hardest hit by the opioid epidemic include West Virginia, New Hampshire, Ohio, the District of Columbia, Maryland, and MA.